Chemical | 27 May 2021
Fine Organic Q4FY21PAT at Rs. 31.79 Cr
The company has posted net profit of Rs.120.32 crores for the 12 months period ended March 31, 2021
The company has posted net profit of Rs.120.32 crores for the 12 months period ended March 31, 2021
It reported total income of Rs.8413.83 crores during the 12 months period ended March 31, 2021
Bayer set up the oxygen plant in a record time of three weeks
It has posted net profit of Rs.127.03 crores for the 12 months period ended March 31, 2021
In FY 2020-21, BCSL introduced 'Better Farms, Better Lives' to support smallholder farmers severely impacted by Covid-19
Ethanol blending is expected to reach 20% by 2025 and the sugar company stocks are expected to soar higher in the coming times
Stamicarbon will continue to develop green technologies while Shchekinoazot will explore the introduction of green technologies at its existing or new enterprises
The decision is consistent with the company’s strategy to grow its integrated additive ingredients portfolio
Revenue from operations for the year ended March 31, 2021 is ?2,239 crore
With the surge of infections in India in the recent days AmphoTLC will address the country's acute liposomal amphotericin B shortage
The company has posted net profit of Rs.117.69 crores for FY 2020-21
The company reported total income of Rs.2441.54 crores during FY 2020-21
Lauryl alcohol prices rose sharply to Rs111 in Q4FY21
The first project of the collaboration focuses on the development of comprehensive pest monitoring and modelling for grapes and pome fruits, specifically apples
Acrylic resin is a plastic product that possesses excellent transparency and light resistance, and boasts a wide range of applications, including automotive light covers, signs, aquarium tanks, coatings and construction materials
The funds will be made available immediately to provide access to medical care and basic supplies in the hardest-hit countries
The turnover of its NPNC Formulations Division (IKKT Undertaking) for FY 2020-2021 is Rs.21.33 Cr
The antibody cocktail is to be administered for the treatment of mild to moderate COVID-19
This marks Glenmark's first synthetic decapeptide injectable approval
BALflu is approved by DCGI for emergency use for the treatment of COVID-19
Subscribe to our newsletter & stay updated.
_195_291.jpg)
